Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 28, 2018
Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysisMário L de Lemos, Isabell Kang, Kimberly SchaffReviews on Environmental Health|December 14, 2005
Exposure pathways and health effects associated with chemical and radiological toxicity of natural uranium: a reviewDoug Brugge, Jamie L de Lemos, Beth OldmixonJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 27, 2025
Lactose intolerance or gastrointestinal adverse drug effect? guidance for oncology pharmacistsLisa Wanbon, Nadine Badry, Mário L de LemosJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 28, 2019
Efficacy of nivolumab four-weekly dosing schedule based on body weightMário L de Lemos, Carrie Kung, Sally WaigneinJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 6, 2006
Leaching of diethylhexyl phthalate from polyvinyl chloride materials into etoposide intravenous solutionsMário L de Lemos, Linda Hamata, Thanh VuJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 18, 2017
Loperamide and cardiac events: Is high-dose use still safe for chemotherapy-induced diarrhea?Mário L de Lemos, Jolene Guenter, Victoria KletasJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 22, 2013
Hazards in determining whether a drug is hazardousNadine Badry, Joan Fabbro, Mario L de LemosJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 28, 2017
A deliberative framework to identify the need for real-life evidence building of new cancer drugs after interim funding decisionLeanne Leung, Mário L de Lemos, Laurel KovacicJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 22, 2016
Rationalizing the use of auxiliary label for oral oncology drugsTonya Ng, Nadine Badry, Mário L de LemosJournal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 6, 2015
Evidence-based practice in times of drug shortageMário L de Lemos, Sally Waignein, Marie de HaanPageof 5